Wednesday, October 09, 2019 4:58:38 AM
I'm pretty sure the Stil team is looking towards Institutional as the end game... When production becomes 'mass production and % profits are realized for ongoing.. I-Hub will just be another set of customers riding the train... to say, not driving the train.
As strange as it may seem to some, the Endocannabinoid system will be at least measured as important as like Vitamins- deficiencies occur. I think that one day it will be admitted to that the Endocannabinoid system will is tied to T-Cell generation.
Ask 100 people and I'll give 10 to one odds no one even is aware when Endocannabinoid systems started in living creatures or what the first known creature developed 'Endo', or likely reason, as known today. I've gotten into discussion with Doctors and nurses and those odds still don't change much but they all admit they are or will be studying up more about it.
We are at the cusp of where humanity was like when understanding Scurvy solutions Vitamin C, or Vitamin D, or K.
Which is why I'm hoping Stil goes the extra step past CBD Isolate in 2021. A Pharmaceutical plant for Cannabission-B may be a dream at this point, but Institutional buyers can make that happen... not so much I-Hubbers.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM